Biomea Fusion, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMEA Nasdaq 2834 biomeafusion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomea Fusion, Inc.

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights - May 5th, 2025 8:05 pm
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Apr 2nd, 2025 1:35 pm
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Apr 1st, 2025 8:01 pm
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Apr 1st, 2025 1:35 pm
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - Mar 31st, 2025 8:10 pm
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Mar 31st, 2025 1:35 pm
Biomea Fusion Announces Leadership Transition - Mar 25th, 2025 11:00 pm
Biomea Fusion announces presentation of icovamenib preclinical, clinical data - Mar 25th, 2025 12:50 pm
Freightos And 2 Other Penny Stocks Worth Watching - Mar 24th, 2025 5:05 pm
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose - Mar 24th, 2025 12:30 pm
Biomea Fusion Insiders Recover Some Losses, Which Stand At US$91k - Mar 22nd, 2025 2:30 pm
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Mar 3rd, 2025 1:00 pm
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes - Feb 27th, 2025 1:00 pm
Promising US Penny Stocks To Watch In February 2025 - Feb 18th, 2025 8:11 pm
Biomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst institutional investors who own 51% - Feb 5th, 2025 2:06 pm
Biomea Fusion to Become a Diabetes & Obesity Medicines Company - Jan 13th, 2025 2:00 pm
3 US Penny Stocks With Market Caps Up To $2B - Jan 9th, 2025 1:11 pm
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study - Jan 7th, 2025 2:00 pm
Here’s Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10 - Jan 6th, 2025 2:04 pm
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 6th, 2025 12:00 pm